ERIC 2018 | Novel ventoclax combinations for CLL
The future of chronic lymphocytic leukemia (CLL) treatment is bright and looking towards novel combinations. Here, Eva Kimby, MD, PhD, of the Karolinska University Hospital, Solna, Sweden, gives us her thoughts on promising novel therapies, including venetoclax combinations. This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
Get great new content delivered to your inboxSign up